{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:04:51Z","timestamp":1785168291084,"version":"3.55.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":167,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:p>\n                    The effect of viral suppression on long\u2010term disease outcome after decompensation in patients with hepatitis B virus (HBV)\u2010related cirrhosis has not been established. The aim of this study was to determine the long\u2010term effect of antiviral therapy (AVT) in patients with HBV\u2010related decompensated cirrhosis. This was a multicenter, prospective, inception cohort study of 707 patients who presented with first\u2010onset decompensated complications, including 284 untreated and 423 antiviral\u2010treated patients (58 previously treated, 253 with early treatment, and 112 with delayed treatment). The primary endpoint was 5\u2010year liver transplantation (LT)\u2010free survival. Secondary endpoints included virological response (VR) and serological response and improvement in liver function. Despite baseline high HBV activity and worse liver function, antiviral\u2010treated patients had significantly better transplant\u2010free survival than untreated patients (5\u2010year survival rates of 59.7% vs. 46.0%, respectively), with more apparent benefits from antivirals in Child\u2010Turcotte\u2010Pugh class B\/C and high\u2010viremia groups. The rate of VR and hepatitis B e antigen seroconversion at 5 years in antiviral\u2010treated patients was 14.2% and 49.1%, respectively. A significant improvement in liver function was observed in treated versus untreated patients, with 33.9% of treated patients delisted for LT. Patients with early treatment had better clinical outcomes than those with delayed treatment. Survival was dependent on antiviral response, being significantly better in responders than in nonresponders or untreated cases. The initial benefit of AVT was negated over time in nonresponders. Antiviral treatment and maintained VR remained independently predictive of survival. The study results were corroborated by propensity score\u2010matching analysis.\n                    <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>\n                    : AVT significantly modifies the natural history of decompensated cirrhosis, improving liver function and increasing survival. The results underscore the importance of promptly administering potent antiviral drugs to patients under consideration for LT. (H\n                    <jats:sc>epatology<\/jats:sc>\n                    2015;61:1808\u20131820)\n                  <\/jats:p>","DOI":"10.1002\/hep.27723","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T18:06:57Z","timestamp":1422382017000},"page":"1809-1820","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":145,"title":["Long\u2010term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus\u2013related cirrhosis"],"prefix":"10.1097","volume":"61","author":[{"given":"Jeong Won","family":"Jang","sequence":"first","affiliation":[{"name":"Department of Internal Medicine,The Catholic University of Korea, College of Medicine,Seoul,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,The Catholic University of Korea, College of Medicine,Seoul,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Soonchunhyang University College of Medicine,Bucheon,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Pusan National University Hospital,Busan,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kyu","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Chonnam National University Medical School,Gwangju,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hyeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Catholic University of Daegu School of Medicine,Daegu,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Yeob","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Hanyang University Guri Hospital,Guri,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hyun","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Hanyang University Guri Hospital,Guri,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Young","family":"Tak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Kyungpook National University Hospital,Daegu,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang\u2010Hyub","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,Yonsei University College of Medicine,Seoul,Korea"},{"name":"Liver Cirrhosis Clinical Research Center,Seoul,Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,3,18]]},"reference":[{"key":"hep27723-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep27723-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-2006-939752","article-title":"Hepatitis B virus\u2010related cirrhosis: natural history and treatment","volume":"26","year":"2006","journal-title":"Semin Liver Dis"},{"key":"hep27723-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/0016-5085(92)91188-A","article-title":"Survival and prognostic indicators in hepatitis B surface antigen\u2010positive cirrhosis of the liver","volume":"103","year":"1992","journal-title":"Gastroenterology"},{"key":"hep27723-bib-0004-20241017","first-page":"77","article-title":"Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis","volume":"21","year":"1995","journal-title":"Hepatology"},{"key":"hep27723-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2012.02.033","article-title":"Hepatitis B virus\u2010related decompensated liver cirrhosis: benefits of antiviral therapy","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep27723-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"hep27723-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","year":"2006","journal-title":"Gastroenterology"},{"key":"hep27723-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/gast.2002.35352","article-title":"Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy","volume":"123","year":"2002","journal-title":"Gastroenterology"},{"key":"hep27723-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.11.007","article-title":"Efficacy of entecavir in treatment\u2010naive patients with hepatitis B virus\u2010related decompensated cirrhosis","volume":"52","year":"2010","journal-title":"J Hepatol"},{"key":"hep27723-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.23952","article-title":"Tenofovir disoproxil fumarate (TDF), emtricitabine\/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep27723-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.24361","article-title":"Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open\u2010label study","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"hep27723-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2893.2012.01600.x","article-title":"Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment\u2010naive patients with HBV\u2010related decompensated cirrhosis","volume":"19","year":"2012","journal-title":"J Viral Hepat"},{"key":"hep27723-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1440-1746.2005.03886.x","article-title":"Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis","volume":"20","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"hep27723-bib-0014-20241017","first-page":"951A","article-title":"Mode of cirrhosis related complication in Korean patients with liver cirrhosis\u2014a prospective multicenter cohort study","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"hep27723-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1349-7006.2011.02170.x","article-title":"Mutational complex genotype of the hepatitis B virus X \/precore regions as a novel predictive marker for hepatocellular carcinoma","volume":"103","year":"2012","journal-title":"Cancer Sci"},{"key":"hep27723-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","year":"2005","journal-title":"J Hepatol"},{"key":"hep27723-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep27723-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","article-title":"Asian\u2010Pacific consensus statement on the management of chronic hepatitis B: a 2008 update","volume":"2","year":"2008","journal-title":"Hepatol Int"},{"key":"hep27723-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"hep27723-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep27723-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3346\/jkms.2005.20.5.816","article-title":"Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea","volume":"20","year":"2005","journal-title":"J Korean Med Sci"},{"key":"hep27723-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2036.2011.04990.x","article-title":"Meta\u2010analysis: oral anti\u2010viral agents in adults with decompensated hepatitis B virus cirrhosis","volume":"35","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"hep27723-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","year":"2004","journal-title":"N Engl J Med"},{"key":"hep27723-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep27723-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2008.03816.x","article-title":"Meta\u2010analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma","volume":"28","year":"2008","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27723","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27723","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201506000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T20:03:12Z","timestamp":1729195392000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201506000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,18]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27723","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725330486.793505195","asserted-by":"object"}]},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,18]]},"assertion":[{"value":"2014-04-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-01-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}